HPSE and COVID-19: Besides heparin as a blood thinner to promote anticoagulation via binding to anti-thrombin III, heparin is also beneficial in COVID-19 by preventing endothelial leakage (inhibition of heparanase) and blocking leukocyte infiltration (Buijsers et al., 2020).